cefepim mip pharma 2 g injektio/infuusiokuiva-aine, liuosta varten
mip pharma gmbh - cefepime - injektio/infuusiokuiva-aine, liuosta varten - 2 g - kefepiimi
naltrexone poa pharma 50 mg tabletti, kalvopäällysteinen
poa pharma scandinavia ab - naltrexoni hydrochloride - tabletti, kalvopäällysteinen - 50 mg - naltreksoni
kaliumjodidi g.l.pharma 65 mg tabletti
g.l. pharma gmbh - potassium iodide - tabletti - 65 mg - kaliumjodidi
revasc
canyon pharmaceuticals ltd. - desirudiinille - laskimotromboosi - antitromboottiset aineet - syvän laskimotromboosin ehkäisy potilailla, jotka saavat elektiivisen lonkan tai polven korvaavan leikkauksen.
methadone g.l. pharma 5 mg tabletti
g.l. pharma gmbh - methadone hydrochloride - tabletti - 5 mg - metadoni
methadone g.l. pharma 10 mg tabletti
g.l. pharma gmbh - methadone hydrochloride - tabletti - 10 mg - metadoni
methadone g.l. pharma 20 mg tabletti
g.l. pharma gmbh - methadone hydrochloride - tabletti - 20 mg - metadoni
methadone g.l. pharma 40 mg tabletti
g.l. pharma gmbh - methadone hydrochloride - tabletti - 40 mg - metadoni
methadone g.l. pharma 60 mg tabletti
g.l. pharma gmbh - methadone hydrochloride - tabletti - 60 mg - metadoni
dasatinib accordpharma
accord healthcare s.l.u. - dasatinibin - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiset aineet - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.